Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Synthesis of no-carrier-added alpha-(/sup 11/C)methyl-L-tryptophan

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5237630
Described here is a synthesis of no-carrier-added alpha-(/sup 11/C)methyl-L-tryptophan based on alkylation with /sup 11/CH/sub 3/I of an anion generated by reacting the Schiff base of L-tryptophan methyl ester with di-isopropylamine. The synthesis requires approximately 30 min after the end of /sup 11/CO/sub 2/ collection and gives alpha-(/sup 11/C)methyl-L-tryptophan in a 20-25% radiochemical yield calculated at the end of the synthesis and without correction for radioactive decay. The specific activity of the final radiopharmaceutical, measured at the end of the synthesis, was around 2000 Ci/mmol. Data confirming the stereospecificity of the synthesis are also presented.
Research Organization:
Montreal Neurological Institute and Hospital (Canada)
OSTI ID:
5237630
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 29:3; ISSN JNMEA
Country of Publication:
United States
Language:
English